Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Finasteride's stability and safety confirmed through precise analytical methods.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Alopecia is a key indicator of thallium poisoning.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Advanced human skin models improve drug development and could replace animal testing.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.